Helios cardio Moves to New Laboratories

Helios Cardio Research.jpg

Helios Cardio unveils its new state-of-the-art research, development, and manufacturing facility in Natick Massachusetts. The brand-new, custom designed laboratory is located within the recently established ABI accelerator campus. The move provides Helios with instant access to a fully functional research environment, with opportunities for expansion within an entrepreneurial community.

Helios Cardio’s Chief Scientific Officer, Dr. Kevin Cornwell, is enthusiastic about the move stating, “We’re enormously excited about this transition into Boston’s MetroWest. It affords us the potential to fast-track our research and development activities towards the next generation of innovative cardiovascular medical devices in anticipation of FDA clearance for CardiaMend.”

Previous
Previous

Helios Cardio announces US FDA 510(k) clearance for a new Pericardial and Epicardial Reconstruction Matrix

Next
Next

Welcome to helios cardio